Search bioRxiv⌕ Search

Biology subjects

Micks, E.

Publications and source records attributed to Micks, E..

2 recordsLinked to original sources

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells

ProblemThe anti-microbial protein granulysin is present in vaginal secretions during the follicular phase of the menstrual cycle but nearly disappears during the luteal phase. The reason for this change is unknown. Method of studyParticipants (n = 23) with regular menstrual cycles collected daily vaginal swabs for granulysin ELISAs. Endocervical cytobrushes, ectocervical biopsies, vaginal biopsies, and PBMC were collected across the cycle to enumerate granulysin-expressing cells by flow cytometry. Cycle phase was determined by daily urinary luteinizing hormone testing and confirmed by serum progesterone levels. ResultsGranulysin levels in secretions were up to 10,000 times higher during menstruation than during the luteal phase (menstruation, median 3,924 pg/mL [IQR 400-17,280]; luteal, median and IQR undetectable [<7.81 pg/mL]). In the endocervical canal, granulysin-expressing cells were much more abundant during menstruation than during the mid-follicular or mid-luteal phases. In contrast, the number of granulysin-expressing cells in the ectocervix and vagina remained stable during the cycle. The most abundant granulysin-expressing cell types in the mucosa were CD8 T cells and NK cells. In a minority of participants, granulysin was consistently detected in luteal-phase swabs; this phenomenon was associated with parity. ConclusionsGranulysin in vaginal secretions is associated with menstruation and concomitant with a spike in granulysin-expressing cells in the endocervical canal. This result explains the much higher granulysin levels in secretions during the follicular than the luteal phase. In contrast, immune cells from ectocervical and vaginal biopsies express granulysin independently of the menstrual cycle, indicating their continuous ability to respond to microbial infection.

immunology↗

The Impact of Delayed Evacuation on the Quality of Human Fetal Tissue

BackgroundDigoxin and other agents are frequently administered to arrest fetal circulation before the evacuation of human fetal tissue (HFT) in pregnancy terminations to address concerns about fetal viability. However, the impact of delayed evacuation on HFT quality remains unknown. Analyzing HFT is critical for diagnosing pregnancies affected by fetal abnormalities and for driving progress in biomedical research. ObjectiveThis study aims to assess the effects of delayed evacuation following fetal circulation cessation on the quality of HFT for both diagnostic and research purposes. Study DesignHFT samples were collected from second-trimester dilation and evacuation (D&E) procedures, with and without agent injection approximately 24 hours prior, as per standard care protocols. We assessed multiple parameters relevant to diagnostics and research, including: 1) cell morphology, 2) cell proliferation, 3) apoptosis, 4) cell viability in culture, and 5) nucleic acid quality. To simulate in utero conditions and determine the timeline for tissue degradation, we incubated brain tissue obtained from D&E without induced demise at 37{degrees}C for up to 18 hours. ResultsWe analyzed 18 HFT samples from D&E procedures performed 19-25 hours after digoxin or potassium chloride (KCl) injection and compared them to 26 HFT samples from immediate evacuations without prior injection. Induced fetal demise resulted in 1) disrupted cell morphology, 2) decreased cell proliferation, 3) increased apoptosis, 4) reduced cell viability in culture, and 5) lower RNA quality. Despite these findings, all samples yielded DNA of sufficient quality for polymerase chain reaction (PCR). ConclusionD&E procedures performed after fetal demise induced by digoxin or KCl lead to decreased HFT quality, limiting its diagnostic and research potential beyond gross tissue evaluation and DNA extraction. Limiting the time between fetal circulation arrest and evacuation may improve HFT quality for clinical and research applications.

pathology↗